Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Vertex Pharmaceuticals Incorporated    VRTX

Delayed Quote. Delayed  - 05/27 09:59:57 pm
90.38 USD   +1.33%
04/27 VERTEX PHARMACE : reports 1Q loss
04/27 VERTEX PHARMACE : Reports First Quarter 2016 Financial Results
04/19 VERTEX PHARMACE : Enterome signs IBD therapy agreement with Vertex
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
Latest news on VERTEX PHARMACEUTICALS INC
04/28 VERTEX PHARMACEUTICALS : to Announce First Quarter 2016 Financial Results on Apr..
04/28 VERTEX PHARMACEUTICALS : Patent Issued for Solid Forms of 3-(6-(1-(2,2-Difluorob..
04/27 VERTEX PHARMACEUTICALS : reports 1Q loss
04/27 VERTEX PHARMACEUTICALS : Reports First Quarter 2016 Financial Results
04/21 VERTEX PHARMACEUTICALS : New Fenamates Study Findings Have Been Reported from Ve..
04/19 VERTEX PHARMACEUTICALS : Enterome signs IBD therapy agreement with Vertex
04/18 S&P 500 MOVERS : Chk, has
04/18 VERTEX PHARMACEUTICALS : Nivalis Therapeutics Appoints David Rodman, MD as Chief..
04/15 NASDAQ 100 MOVERS : Vrtx, nvda
04/15 VERTEX PHARMACEUTICALS : to Announce First Quarter 2016 Financial Results on Apr..
04/07 VERTEX PHARMACEUTICALS : Patent Issued for Methods of Regioselective Synthesis o..
04/07 BED BATH & BEYOND : Nasdaq 100 Movers: EBAY, BBBY
04/06 Mutual of America Capital Management LLC Acquires 173 Shares of Vertex Pharma..
04/06 NASDAQ 100 MOVERS : Wdc, vrtx
04/06DJHealth-Care Companies Lead U.S. Stocks Higher
04/05 VERTEX PHARMACEUTICALS : India Denies Vertex Patent on Cystic Fibrosis Drug Orka..
03/23 VERTEX PHARMACEUTICALS : Nasdaq 100 Movers: VRTX, NVDA
03/17 VERTEX PHARMACEUTICALS : to Present at the Barclays Healthcare Conference on Mar..
03/10 VERTEX PHARMACEUTICALS : to Present at the Barclays Healthcare Conference on Mar..
03/08 VERTEX PHARMACEUTICALS : Receives Australian Approval for ORKAMBI® (lumacaftor/i..
03/03 VERTEX PHARMACEUTICALS : Awards $1 Million in Grants to 18 Non-profit Organizati..
02/24 VERTEX PHARMACEUTICALS : Awards $1 Million in Grants to 18 Non-profit Organizati..
02/18 VERTEX PHARMACEUTICALS : Receives Complete Response Letter from U.S. FDA for Use..
02/18 VERTEX PHARMACEUTICALS : to Present at Upcoming Investor Conferences
02/16 VERTEX PHARMACEUTICALS : What Vertex’s Results Mean for Corbus, ProQR, and..
02/16 VERTEX PHARMACEUTICALS INCORPORATED : What Vertex’s Results Mean for Corbus, Pro..
02/11 VERTEX PHARMACEUTICALS : Patent Issued for Automated Developer for Immuno-Staine..
02/11 VERTEX PHARMACEUTICALS : Report Summarizes Rifampin Therapy Study Findings from ..
02/09 VERTEX PHARMACEUTICALS : to Present at Upcoming Investor Conferences
02/08 VERTEX PHARMACEUTICALS : FDA declines to approve Vertex's Kalydeco in people wit..
02/05 VERTEX PHARMACEUTICALS : Receives Complete Response Letter from U.S. FDA for Use..
02/04 VERTEX PHARMACEUTICALS : Health Canada Approves PrORKAMBI® lumacaftor/ivacaftor ..
02/04 VERTEX PHARMACEUTICALS : Findings from Vertex Pharmaceuticals Inc. Reveals New F..
01/28DJU.S. HOT STOCKS : Hot Stocks to Watch
01/27 VERTEX PHARMACEUTICALS : 4Q tops expectations on strong Orkambi sales
01/27 VERTEX PHARMACEUTICALS : Reports Full-Year and Fourth Quarter 2015 Financial Res..
01/26 VERTEX PHARMACEUTICALS : Health Canada Approves PrORKAMBI® (lumacaftor/ivacaftor..
01/14 VERTEX PHARMACEUTICALS : Announces Upcoming Presentation at the J.P. Morgan Heal..
01/11 NASDAQ 100 MOVERS : Lbtya, adi
01/10 VERTEX PHARMACEUTICALS : Outlines 2016 Business Priorities to Support the Discov..
01/07 VERTEX PHARMACEUTICALS : Mass Innovation Labs Spurs Partnerships between Members..
01/05 VERTEX PHARMACEUTICALS : Announces Upcoming Presentation at the J.P. Morgan Heal..
2015 VERTEX PHARMACEUTICALS : New Intercellular Signaling Peptides and Proteins Study..
2015 VERTEX PHARMACEUTICALS : Assigned Patent
2015 VERTEX PHARMACEUTICALS : Expert not convinced by new drug
2015 VERTEX PHARMACEUTICALS : Patent Issued for Dosage Units of 3-(6-(1-(2,2-Difluoro..
2015 VERTEX PHARMACEUTICALS : Appoints Michael J. Parini as Executive Vice President ..
2015 VERTEX PHARMACEUTICALS : Assigned Patent
2015 VERTEX PHARMACEUTICALS : Receives EU Approval for ORKAMBI® lumacaftor/ivacaftor,..
2015 VERTEX PHARMACEUTICALS : Receives Two EU Approvals for KALYDECO® ivacaftor for P..
2015 VERTEX PHARMACEUTICALS : to Present at the Piper Jaffray Healthcare Conference o..
2015 VERTEX PHARMACEUTICALS : EC grants marketing authorisation for Vertex's ORKAMBI ..
2015 VERTEX PHARMACEUTICALS : Appoints Michael J. Parini as Executive Vice President ..
2015 VERTEX PHARMACEUTICALS : Receives EU Approval for ORKAMBI® (lumacaftor/ivacaftor..
2015 VERTEX PHARMACEUTICALS : Receives Two EU Approvals for KALYDECO® (ivacaftor) for..
2015 VERTEX PHARMACEUTICALS : Assigned Patent
2015 VERTEX PHARMACEUTICALS : to Present at the Credit Suisse Healthcare Conference o..
2015 VERTEX PHARMACEUTICALS : Goldberg Law PC Announces an Investigation of Claims ag..
2015 VERTEX PHARMACEUTICALS : Studies from Vertex Pharmaceuticals Reveal New Findings..
2015 VERTEX PHARMACEUTICALS : and CRISPR Therapeutics Establish Collaboration to Use ..
2015 VERTEX PHARMACEUTICALS : to Present at the Credit Suisse Healthcare Conference o..
2015 VERTEX PHARMACEUTICALS : Goldberg Law PC Announces an Investigation of Claims ag..
2015 VERTEX PHARMACEUTICALS : Law Offices of Howard G. Smith : Commences Investigatio..
2015 VERTEX PHARMACEUTICALS INCORPORATED : Pomerantz Law Firm Investigates Claims On ..
2015 VERTEX PHARMACEUTICALS : MA Management's Discussion and Analysis of Financial Co..
2015 VERTEX PHARMACEUTICALS : reports 3Q loss
2015 VERTEX PHARMACEUTICALS : Reports Third Quarter 2015 Financial Results
2015 VERTEX PHARMACEUTICALS : Cambridge startup ink gene-editing agreement
2015 VERTEX PHARMACEUTICALS : Pharma Enters into Research Collaboration with CRISPR T..
2015 VERTEX PHARMACEUTICALS : and CRISPR Therapeutics Establish Collaboration to Use ..
2015 VERTEX PHARMACEUTICALS : to Announce Third Quarter 2015 Financial Results on Oct..
2015 VERTEX PHARMACEUTICALS : Supplemental New Drug Application for Use of KALYDECO® ..
2015 VERTEX PHARMACEUTICALS : Patent Issued for Solid Forms of 3-(6-(1-(2,2-Difluorob..
2015 VERTEX PHARMACEUTICALS : to Announce Third Quarter 2015 Financial Results on Oct..
2015 VERTEX PHARMACEUTICALS : Levi & Korsinsky, LLP Announces an Investigation Involv..
1  2  3  4  5  6  7Next
Advertisement
News chart
Full-screen chart
Income Statement Evolution
More Financials